WANY
VNRX icon

Wealthspire Advisors (New York)’s VolitionRx Ltd VNRX Stock Holding History

Wealthspire Advisors (New York)’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.8K Buy
45,000
+34,000
+309% +$82K ﹤0.01% 1247
2026
Q1 		$44.4K Buy
+11,000
New +$52.5K ﹤0.01% 910

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Wealthspire Advisors (New York)'s VNRX Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its VolitionRx Ltd (VNRX) stake by 309% in Q2 2026, buying an estimated $82K and bringing the position to 45,000 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Wealthspire Advisors (New York) first reported a position in VNRX in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Wealthspire Advisors (New York) held 45,000 shares of VolitionRx Ltd worth $60.8K as of Q2 2026.
  • Wealthspire Advisors (New York) bought 34,000 VolitionRx Ltd shares in Q2 2026, an estimated $82K.
  • VolitionRx Ltd made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1247 holding.
  • Wealthspire Advisors (New York) first reported a position in VolitionRx Ltd in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.